Metabolic, Vascular and Cognitive Effects of Treatment With Anthocyanins
NCT02409446, Not applicable, Completed, Helse Stavanger HF
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Metabolic, Vascular and Cognitive Effects of Treatment With Anthocyanins | ClinicalTrials.gov |
| NCT number | NCT02409446 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 54 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Helse Stavanger HF | ClinicalTrials.gov |
| Conditions | Coronary Disease, Inflammation, Cognitive Impairment | ClinicalTrials.gov |
| Interventions | Anthocyanin | ClinicalTrials.gov |
| First posted | 2015-04-06 | ClinicalTrials.gov |
| Last updated | 2019-02-18 | ClinicalTrials.gov |
Registered outcomes 11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Inflammation as measured by cytokines in blood | 16 weeks | IL1, IL6, IL10, TNFa | ClinicalTrials.gov |
| Primary | Effect on blood lipids as measured by serum Levels of Cholesterol, triglycerides, cholesterol metabolites | 16 weeks | Serum Level measurement of Cholesterol, triglycerides, cholesterol metabolites | ClinicalTrials.gov |
| Primary | Effects on oxidative stress as measured by Blood Levels of lipid peroxidation markers, 4-hydroxymenal protein oxydation marker, total protein carbonyl | 16 weeks | Blood Levels of lipid peroxidation markers, 4-hydroxymenal protein oxydation marker, total protein carbonyl | ClinicalTrials.gov |
| Primary | Effects on antioxidants as measured by Blood levels of vitamin E, vitamin C, vitamin A, total plasma antioxidant capacity, glutathion | 16 weeks | Blood levels of vitamin E, vitamin C, vitamin A, total plasma antioxidant capacity, glutathion | ClinicalTrials.gov |
| Primary | Number of participants With adverse events | 16 weeks | Active questioning for adverse events | ClinicalTrials.gov |
| Secondary | Effects on memory (CERAD memory test) | 16 weeks | CERAD memory test, immediate and delayed score | ClinicalTrials.gov |
| Secondary | Effects on attention (Trail making A and B) | 16 weeks | Trail making A and B | ClinicalTrials.gov |
| Secondary | Effects on executive functioning (Stroop test) | 16 weeks | Stroop test | ClinicalTrials.gov |
| Secondary | Effects on blood pressure | 16 weeks | Blood pressure (mm/Hg) in sitting position | ClinicalTrials.gov |
| Secondary | Effects on heart rate (ECG) | 16 weeks | ECG | ClinicalTrials.gov |
| Secondary | Effect on Cardiac output (Blood Levels of natriuretic peptides) | 16 weeks | Blood Levels of natriuretic peptides | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 31244884 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)